Lilly Diabetes has released an Android version of its Glucagon mobile app, which until now was an iPhone exclusive title.

“The new version of the Lilly Glucagon Mobile App leverages the power of Android mobile technology, helping us reach even more caregivers and providing another opportunity to support people living with type 1 diabetes,” said Matt Caffrey, senior director, consumer marketing, Lilly Diabetes.

Serving as a teaching tool for treatment with Lilly Glucagon for Injection (rDNA origin) during a severe low blood sugar episode, the application is designed for caregivers and healthcare providers who support people with diabetes. It helps people practice the injection steps ahead of time, which may help them feel better prepared to assist.

Other Glucagon features include a kit location log, so kits can be easily located during an emergency, and an expiration date log that sends a reminder when a kit is getting close to its expiration date, so a new kit can be obtained before this date.

Glucagon is a treatment for insulin coma or insulin reaction resulting from severe low blood sugar. It should not be used if a user has pheochromocytoma or if he/she is allergic to Glucagon.

The Lilly Glucagon mobile app for both Android and iOS devices is available as a free download.